Open access · CC-BY
via OpenAlex
6612 Both Overt And Mild Hypercortisolism Accelerate Biological Aging
Kang Yu, Jitender S. Saini, Joshua N. Farr, F Vanessa, Sundeep Khosla, Irina Bancos
Journal of the Endocrine Society · 2024
Abstract
Abstract Disclosure: K. Yu: None. J. Saini: None. J.N. Farr: None. F. Vanessa: None. S. Khosla: None. I. Bancos: Advisory Board Member; Self; AstraZeneca, Adrenas, Neurocrine, Spruce, Recordati, Xeris, Novo Nordisk, HRA Pharmaceuticals, Sparrow, Diurnal, Corcept. Research Investigator; Self; HRA Pharmaceuticals, Recordati. Importance: Patients with both mild autonomous cortisol secretion (MACS) and overt Cushing syndrome (CS) demonstrated high prevalence of aging-related morbidity and an increased mortality. Objective: To determine whether p16INK4a in T cell, a cell cycle enzyme that associated with chronological aging and cell senescence(definition), is associated with hypercortisolism and hypercortisolism-related comorbidities. Design, Setting, and Participants: In this single-center cross-sectional study, we prospectively recruited consecutive patients with hypercortisolism between July 1, 2020 and August 24 2022. Patients were included if they were diagnosed with Cushing syndrome (CS) or mild autonomous cortisol secretion (MACS). Age- (± 2 years) and sex-matched referent subjects without known adrenal disorders were included if abdominal imaging was available. Participants on exogenous glucocorticoids within 3 months prior were excluded. Exposure: Presence of hypercortisolism (MACS and CS). Main Outcomes and Measures: Primary outcomes included p16INK4a, advanced glycation end products (AGE) reader result, Frailty Index score, frailty (defined as frailty index>0.31), and physical performances in patients and matched referents at index date. Secondary outcomes included correlation between biological age markers, hormonal workup and the risk of comorbidities. p16INK4a expression analysis was adjusted for age, sex, smoking, and alcohol use for all analyses except for associations with CVD and frailty. Results: Of 85 patients (87% women, mean age 53 years), 51 (60%) had MACS (34 had matched referents), 34 (40%) had overt CS (16 had matched referents). Patients with CS demonstrated a median 1.9-fold higher p16INK4a expression (P<.001), and patients with MACS showed a median of 1.70-fold p16INK4a expression (P=.013), when compared to referent subjects. Age- and sex-adjusted p16INK4a expression was associated with frailty index score (r=0.23, P=.035), time-up-and-go test (r=0.28, P=.048), gait speed (r=-0.36, P=.035), but not with AGE reader result, 6-minute walk test, or hand grip measurement. The p16INK4a expression was associated with history of cardiovascular disease (age-adjusted odds ratio (aOR)=3.70, 95% confidence interval (CI), 1.20-11.43) and frailty (aOR=2.27, 95%CI, 1.04-4.98). Conclusion and relevance: We demonstrated evidence of cell senescence in both patients with CS and patients with MACS. Further studies need to determine the impact of surgical, cortisol-lowering, and senolytic medical therapies in MACS on cell senescence and associated aging-related comorbidities. Presentation: 6/1/2024
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1210/jendso/bvae163.126
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Yu, K., Saini, J.S., Farr, J.N., Vanessa, F., Khosla, S., & Bancos, I. (2024). 6612 Both Overt And Mild Hypercortisolism Accelerate Biological Aging. <em>Journal of the Endocrine Society</em>. https://doi.org/10.1210/jendso/bvae163.126
Vancouver
Yu K, Saini JS, Farr JN, Vanessa F, Khosla S, Bancos I. 6612 Both Overt And Mild Hypercortisolism Accelerate Biological Aging. Journal of the Endocrine Society. 2024. doi:10.1210/jendso/bvae163.126.
BibTeX
@article{kang2024BothOv,
title = {6612 Both Overt And Mild Hypercortisolism Accelerate Biological Aging},
author = {Kang Yu and Jitender S. Saini and Joshua N. Farr and F Vanessa and Sundeep Khosla and Irina Bancos},
journal = {Journal of the Endocrine Society},
year = {2024},
doi = {10.1210/jendso/bvae163.126},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical interventions in aging 2026
Open access · OA
Prognostic Value of the Frailty Index in Patients with Severe Aortic Regurgitation Undergoing Transcatheter Aortic Valve Replacement.
University of Southern California 2021
Open access · US-GOV
Frailty in Individuals With Advanced Heart Failure Part 2
Puerta de Hierro University Hospital 2017
Open access · US-GOV
Characterization of the Nutritional Status in the Patient With Liver Cirrhosis and Impact of a Nutritional Intervention With Nutritional Supplements With BRCA vs. Standard Treatment in the Subgroup of Patients With Sarcopenia
Gerontology 2009
Open access · OA
Frailty and 10-Year Mortality in Community-Living Mexican American Older Adults
The Journal of Clinical Endocrinology & Metabolism 2013
Open access · OA
Risk of Developing Diabetes and Cardiovascular Disease in Metabolically Unhealthy Normal-Weight and Metabolically Healthy Obese Individuals
The Journal of arthroplasty 2026
Citation only